Results 151 to 160 of about 7,381 (220)

A broad-spectrum antibiotic, DCAP, reduces uropathogenic Escherichia coli infection and enhances vorinostat anticancer activity by modulating autophagy [PDF]

, 2018
Allavena, Giulia, Debellis, Doriana, Grimaldi, Benedetto, Joshi, Chetanchandra S, Marotta, Roberto, Mysorekar, Indira U   +5 more
core   +1 more source

NovelHTI: An Interpretable Pathway-Enhanced Framework for De Novo Target Prediction of Medicinal Herbs via Cross-Scale Heterogeneous Information Fusion. [PDF]

Pharmaceuticals (Basel)
Cheung Y.
europepmc   +1 more source

Editorial: Advancing drug discovery with AI: drug-target interactions, mechanisms of action, and screening. [PDF]

Front Pharmacol
Li X, Xing J, Zhang S, Zhou J.
europepmc   +1 more source

Synergistic mesenchymal and neural stem cell therapy: Advancing neurorestoration in cerebral infarction. [PDF]

World J Stem Cells
Ebrahim NAA, Othman MO, Tahoun NS, Farghaly TA, Soliman SMA.   +4 more
europepmc   +1 more source

Docking 14 Million Virtual Isoquinuclidines against the μ and κ Opioid Receptors Reveals Dual Antagonists-Inverse Agonists with Reduced Withdrawal Effects. [PDF]

ACS Cent Sci
Vigneron SF, Ohno S, Braz J, Kim JY, Kweon OS, Webb C, Billesbølle CB, Srinivasan K, Bhardwaj K, Irwin JJ, Manglik A, Basbaum AI, Ellman JA, Shoichet BK.   +13 more
europepmc   +1 more source

A systems approach identifies MERTK as a therapeutic vulnerability in ZFTA-RELA-driven ependymomas. [PDF]

Proc Natl Acad Sci U S A
Chan M, Zhu S, Russell ZR, Arora S, Arakaki AKS, Vaz JM, Kumasaka D, Szulzewsky F, Michealraj A, Holland EC, Gujral TS.   +10 more
europepmc   +1 more source

Enhancing the confidence of potential targets enriched by similarity-centric models: the crucial role of the similarity threshold. [PDF]

Front Pharmacol
Tong LF, Ge YJ, Yang SQ.
europepmc   +1 more source

7th German Conference on Chemoinformatics: 25 CIC-Workshop : Goslar, Germany, 6 - 8 November 2011 ; meeting abstracts / Edited by Frank Oellien, Uli Fechner and Thomas Engel [PDF]

, 2012
Engel, Thomas, Fechner, Uli, Oellien, Frank   +2 more
core  

LEAP-008: pembrolizumab plus lenvatinib after immunotherapy in non-small cell lung cancer. [PDF]

J Thorac Dis
Fukuda K.
europepmc   +1 more source

Recent Insights in Multi-Target Drugs in Pharmacology and Medicinal Chemistry. [PDF]

ChemMedChem
Cemali SH, Poyraz S, Belveren S, Taş S, Tamer MA, Döndaş NY, Döndaş HA, Sansano JM.   +7 more
europepmc   +1 more source